This federal contract award, valued at $6,966.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of XELJANZ XR 11 MG TABLET, a specialty medication. The contract has a firm fixed-price delivery order type and an ultimate completion date of November 4, 2024.
Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.
The contract award does not have a set-aside designation, indicating open competition. The DLA is a defense agency responsible for providing logistics, acquisition, and technical services to the U.S. Armed Forces, making Amerisourcebergen a critical supplier of pharmaceutical and medical products to military healthcare facilities and programs.
Generated 2/27/25, 1:27 PM